Assembly Biosciences (ASMB) Total Liabilities (2010 - 2026)

Assembly Biosciences' Total Liabilities history runs 17 years deep, the most recent figure standing at $36.9 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 48.67% year-over-year to $36.9 million; the TTM figure through Mar 2026 stood at $36.9 million (down 48.67% YoY), while the FY2025 annual figure was $50.8 million, down 40.75% from the prior year.
• Total Liabilities was $36.9 million for Q1 2026 at Assembly Biosciences, down from $50.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $95.7 million in Q4 2023 to a low of $9.9 million in Q3 2023.
• Historically, Total Liabilities has averaged $47.7 million across 5 years, with a median of $50.8 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities sank 49.65% in 2022, then soared 648.96% in 2024.
• A 5-year view of Total Liabilities shows it stood at $19.1 million in 2022, then jumped by 400.4% to $95.7 million in 2023, then slipped by 10.36% to $85.8 million in 2024, then slumped by 40.75% to $50.8 million in 2025, then decreased by 27.42% to $36.9 million in 2026.
• The last three Total Liabilities figures came in at $36.9 million (Q1 2026), $50.8 million (Q4 2025), and $57.3 million (Q3 2025), per Business Quant data.